9 June 2016 - EFPIA notes the article published by Reuters, entitled: “Industry weighs radical shake up of European Drug pricing”.

As an industry, we acknowledge the affordability challenges faced by healthcare systems, under pressure from rising health care demand. Our industry wants to be part of the solution in making medicines more accessible and healthcare more sustainable.

As part of that process, the internal EFPIA document referenced in the article was developed by a working group from across the EFPIA membership, to support continued dialogue with governments and healthcare systems in finding solutions to make medicines accessible and healthcare more sustainable, whilst securing future medical innovation.

People all over Europe are living longer, healthier and more productive lives thanks to the innovative medicines developed by our industry, and with over 7000 medicines in development, the exciting new wave of pharmaceutical innovation will play a key role in addressing the challenges faced by patients and healthcare systems.

For more details, go to: http://www.efpia.eu/mediaroom/338/43/EFPIA-response-to-Reuters-article-quot-Industry-weighs-radical-shake-up-of-European-Drug-Pricing-quot